Pharmaceuticals

Increasing Cardiovascular Disease Prevalence Driving Growth in the Calcitonin Salmon Market

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Calcium Channel Blocker Market In 2026 And What Value Is Projected For 2030?

The calcium channel blocker market has experienced robust growth in recent years. It is projected to increase from $16.46 billion in 2025 to $17.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. The expansion observed in the past can be attributed to factors such as the rising prevalence of hypertension, an increasing incidence of cardiovascular disorders, the growing aging population, the early adoption of dihydropyridine drugs, and awareness campaigns conducted by healthcare providers.

The calcium channel blocker market size is projected to experience substantial growth over the coming years, reaching $23.12 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This anticipated expansion during the forecast period is primarily driven by advancements in sustained-release formulations, a growing emphasis on personalized medicine, the integration of digital cardiac monitoring, the broadening of homecare services, and increasing capital directed towards combination therapies. Key developments anticipated in this period include personalized hypertension management, the creation of new combination therapies, sophisticated cardiac safety monitoring technologies, formulations tailored for pediatric and geriatric populations, and innovative oral sustained-release formulations.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9428&type=smp

What Major Drivers Are Influencing Demand In The Calcium Channel Blocker Market?

The increasing incidence of cardiovascular diseases is projected to significantly boost the expansion of the calcium channel blocker market. Cardiovascular disease encompasses various conditions affecting the heart or blood vessels, and calcium channel blockers (CCBs) are vital in reducing the risk of heart failure and stroke. As a result, the growing prevalence of these cardiovascular conditions will lead to an elevated demand for calcium channel blockers. For instance, data from the American Heart Association, a US-based non-profit organization, revealed in January 2024 that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 recorded in 2023. This upward trend in cardiovascular disease prevalence is therefore a primary driver behind the growth of the calcium channel blocker market.

What Are The Key Segments Of The Calcium Channel Blocker Market?

The calcium channel blocker market covered in this report is segmented –

1) By Drug Class: Dihydropyridine, Benzothiazepine, Phenylalkylamine, Other Drug Classes

2) By Disease Indications: Hypertension, Chest Pain, Arrhythmias

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

What Key Trends Are Influencing The Development Of The Calcium Channel Blocker Market?

Key companies operating in the calcium channel blocker market are concentrating on developing technological advancements, such as self-administered nasal spray formulations for acute arrhythmia management. These innovations aim to provide rapid symptom control, enhance patient convenience, and reduce hospital visits. A nasal spray formulation delivers the active calcium channel blocker directly through the nasal mucosa, enabling faster absorption compared to traditional oral tablets and avoiding the necessity of intravenous administration in clinical environments. For instance, in July 2025, Milestone Pharmaceuticals, a U.S.-based biopharmaceutical company, received FDA acceptance for the review of Cardamyst (etripamil) nasal spray, designed for paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation with rapid ventricular rate (AFib RVR). The product is a fast-acting, non-dihydropyridine L-type calcium channel blocker delivered intranasally, facilitating rapid AV node conduction modulation, restoring normal rhythm without the need for hospital supervision, and allowing patients to manage episodes at home.

Who Are The Leading Companies Operating In The Calcium Channel Blocker Market?

Major companies operating in the calcium channel blocker market are Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bausch Health Companies Inc., Lupin Pharmaceuticals Inc., Cadila Healthcare Limited, Covis Pharma BV, Glenmark Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sofgen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knoll Healthcare Private Limited, Sanofi S.A., Clearsynth Labs Ltd., Searle LLC, Bayer AG, AstraZeneca plc, Wyeth-Ayerst Lederle Inc., AbbVie Inc., Silvergate Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd.

Read the full calcium channel blocker market report here:

https://www.thebusinessresearchcompany.com/report/calcium-channel-blocker-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Calcium Channel Blocker Market?

North America was the largest region in the calcium channel blocker market in 2025. The regions covered in the calcium channel blocker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Calcium Channel Blocker Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9428&type=smp

Browse Through More Reports Similar to the Global Calcium Channel Blocker Market 2026, By The Business Research Company

Calcium Channel Blocker Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-channel-blocker-global-market-report

Calcium Gluconate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-gluconate-global-market-report

Calcium Carbide Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-carbide-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795